Literature DB >> 1580286

Microalbuminuria: a risk factor for vascular and renal complications of hypertension.

N M Kaplan1.   

Abstract

The kidneys are not only involved in the development of hypertension, but they are also often damaged if the disease is not controlled. Microalbuminuria occurs early and is easily diagnosed. However, microalbuminuria is not detected on routine Albustix testing, which has a sensitivity limit of 300 mg/L. Urinary albumin excretion, therefore, should be routinely determined by radioimmunoassay or other techniques so that appropriate therapies can be instituted to prevent nephropathy.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1580286

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  4 in total

1.  Impaired glucose tolerance and its co-variates among 2079 non-diabetic elderly subjects. Ten-year mortality and morbidity in the CASTEL study. CArdiovascular STudy in the ELderly.

Authors:  E Casiglia; P Pauletto; A Mazza; G Ginocchio; G di Menza; L Pavan; P Tramontin; M Capuani; A C Pessina
Journal:  Acta Diabetol       Date:  1996-12       Impact factor: 4.280

2.  Albuminuria and proteinuria in hospitalized patients as measured by quantitative and dipstick methods.

Authors:  M J Pugia; J F Wallace; J A Lott; R Sommer; K E Luke; Z K Shihabi; M Sheehan; J M Bucksa
Journal:  J Clin Lab Anal       Date:  2001       Impact factor: 2.352

3.  A cross-sectional and 10-year prospective study of postmenopausal estrogen therapy and blood pressure, renal function, and albuminuria: the Rancho Bernardo Study.

Authors:  Maple M Fung; Sameer Poddar; Ricki Bettencourt; Simerjot Kaur Jassal; Elizabeth Barrett-Connor
Journal:  Menopause       Date:  2011-06       Impact factor: 2.953

4.  Endothelins and markers of renal damage in recently diagnosed hypertensive patients.

Authors:  Antonia Maldonado-Martín; Dolores Rueda-Illescas; Blas Gil-Extremera; Leticia Soriano-Carrascosa; Trinidad Alonso-Morales; Francisco García-Pérez; José García-Chicano; Juan de Dios Luna del Castillo
Journal:  J Clin Hypertens (Greenwich)       Date:  2002 Sep-Oct       Impact factor: 3.738

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.